Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 116 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 02/01/21
Due: 02/01/22
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 09/02/17
End: 09/02/18
Due: 09/02/19
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 03/25/18
End: 08/25/20
Due: 08/25/21
Phase: N/A
Priority: Normal
Start: 06/02/18
End: 08/20/20
Due: 08/20/21
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 09/01/18
Due: 09/01/19
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 09/01/19
Due: 09/01/20
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 09/02/17
End: 09/02/18
Due: 09/02/19
Phase: N/A
Priority: Normal
Start: 09/01/15
End: 10/15/16
Due: 10/15/17
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 01/01/21
Due: 01/01/22
Phase: N/A
Priority: Normal
Start: 11/30/17
End: 08/30/19
Due: 08/30/20
Phase: N/A
Priority: Normal
Start: 11/30/17
End: 08/30/19
Due: 08/30/20
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 10/01/20
Due: 10/01/21
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 06/01/19
Due: 06/01/20
Phase: N/A
Priority: Normal
Start: 07/01/19
End: 07/01/20
Due: 07/01/21
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
Phase: N/A
Priority: Normal
Start: 05/20/19
End: 07/05/20
Due: 07/05/21
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 04/05/18
End: 08/05/20
Due: 08/05/21
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/18
Due: 07/01/19
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 09/01/19
Due: 09/01/20
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 08/01/21
Due: 08/01/22
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 08/31/15
Due: 08/31/16